These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 33407484

  • 1. Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.
    Chung H, Kim Y, Park CH, Kim IS, Kim JY, Min PK, Yoon YW, Kim TH, Lee BK, Hong BK, Rim SJ, Kwon HM, Lee KA, Choi EY.
    Cardiovasc Ultrasound; 2021 Jan 06; 19(1):4. PubMed ID: 33407484
    [Abstract] [Full Text] [Related]

  • 2. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H, Seidelmann SB, Vigneault D, Abbasi SA, Yang E, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Jerosch-Herold M, Bluemke DA, Ho C, Neilan TG.
    J Cardiovasc Magn Reson; 2017 Dec 28; 19(1):107. PubMed ID: 29284499
    [Abstract] [Full Text] [Related]

  • 3. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.
    J Cardiovasc Magn Reson; 2009 Sep 09; 11(1):34. PubMed ID: 19740409
    [Abstract] [Full Text] [Related]

  • 4. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
    Zhu Y, Park EA, Lee W, Kim HK, Chu A, Chung JW, Park JH.
    Eur Radiol; 2015 Apr 09; 25(4):1190-200. PubMed ID: 25597022
    [Abstract] [Full Text] [Related]

  • 5. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
    Fujimoto K, Inoue K, Saito M, Higashi H, Kono T, Uetani T, Aono J, Nagai T, Nishimura K, Suzuki J, Okura T, Ikeda S, Nakatani S, Higaki J.
    Echocardiography; 2018 Aug 09; 35(8):1138-1148. PubMed ID: 29648690
    [Abstract] [Full Text] [Related]

  • 6. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA.
    Int J Cardiovasc Imaging; 2019 Jul 09; 35(7):1309-1318. PubMed ID: 30790116
    [Abstract] [Full Text] [Related]

  • 7. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O, Unlu S, Kilic DI, Sherif SA, Opan S, Kemal HS, Ozmen E, Tuner H, Bingol G, Barutcu A, Nasifov M, Bakan S, Goktekin O.
    Kardiologiia; 2023 Feb 28; 63(2):52-58. PubMed ID: 36880144
    [Abstract] [Full Text] [Related]

  • 8. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ, Choi HM, Yoon YE, Kim HL, Lee SP, Kim HK, Kim YJ, Cho GY, Zo JH, Sohn DW.
    PLoS One; 2016 Feb 28; 11(6):e0157433. PubMed ID: 27336444
    [Abstract] [Full Text] [Related]

  • 9. Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking.
    Wang J, Ma X, Zhao K, Yang S, Yang K, Yu S, Yin G, Dong Z, Song Y, Cui C, Li J, Zhao S, Chen X.
    Eur Radiol; 2024 Feb 28; 34(2):1026-1036. PubMed ID: 37635167
    [Abstract] [Full Text] [Related]

  • 10. An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography.
    Fang H, Tang H, Li P, Xiong L, Hu G, Li L, Yu Y, Zhao B.
    Echocardiography; 2017 Mar 28; 34(3):407-414. PubMed ID: 28130861
    [Abstract] [Full Text] [Related]

  • 11. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
    Sivalokanathan S, Zghaib T, Greenland GV, Vasquez N, Kudchadkar SM, Kontari E, Lu DY, Dolores-Cerna K, van der Geest RJ, Kamel IR, Olgin JE, Abraham TP, Nazarian S, Zimmerman SL, Abraham MR.
    JACC Clin Electrophysiol; 2019 Mar 28; 5(3):364-375. PubMed ID: 30898240
    [Abstract] [Full Text] [Related]

  • 12. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y, Yin G, Jiang Y, Song L, Zhao S, Lu M.
    J Cardiovasc Magn Reson; 2020 Jan 02; 22(1):1. PubMed ID: 31898543
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R, Zamorano JL, Fernández-Méndez M, Esteban A, Plaza-Martin M, González-Gómez A, Carbonell A, Rincón LM, Nácher JJJ, Fernández-Golfín C.
    Int J Cardiovasc Imaging; 2019 Jun 02; 35(6):1055-1065. PubMed ID: 30706353
    [Abstract] [Full Text] [Related]

  • 14. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT, Silva Vieira M, Kutty S, Lotz J, Hasenfu G, Chiribiri A, Schuster A.
    Invest Radiol; 2017 Mar 02; 52(3):177-185. PubMed ID: 27741021
    [Abstract] [Full Text] [Related]

  • 15. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
    Germans T, Rüssel IK, Götte MJ, Spreeuwenberg MD, Doevendans PA, Pinto YM, van der Geest RJ, van der Velden J, Wilde AA, van Rossum AC.
    J Cardiovasc Magn Reson; 2010 Mar 15; 12(1):13. PubMed ID: 20230637
    [Abstract] [Full Text] [Related]

  • 16. "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
    Tondi L, Pica S, Crimi G, Disabato G, Figliozzi S, Camporeale A, Bernardini A, Tassetti L, Milani V, Piepoli MF, Lombardi M.
    Int J Cardiol; 2024 Aug 01; 408():132135. PubMed ID: 38705206
    [Abstract] [Full Text] [Related]

  • 17. Association of left atrial reservoir function with left atrial structural remodeling related to left ventricular dysfunction in asymptomatic patients with hypertension: evaluation by two-dimensional speckle-tracking echocardiography.
    Miyoshi H, Oishi Y, Mizuguchi Y, Iuchi A, Nagase N, Ara N, Oki T.
    Clin Exp Hypertens; 2015 Aug 01; 37(2):155-65. PubMed ID: 25050647
    [Abstract] [Full Text] [Related]

  • 18. Assessment of left atrial function in patients with hypertrophic cardiomyopathy using two-dimensional strain: a comparison with volume-derived values.
    Huang J, Yan ZN, Rui YF, Fan L, Shen D, Chen DL.
    Minerva Cardioangiol; 2018 Feb 01; 66(1):26-37. PubMed ID: 28752727
    [Abstract] [Full Text] [Related]

  • 19. Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Chung H, Kim Y, Park CH, Kim JY, Min PK, Yoon YW, Kim TH, Lee BK, Hong BK, Rim SJ, Kwon HM, Lee KA, Choi EY.
    J Cardiovasc Magn Reson; 2021 Mar 04; 23(1):18. PubMed ID: 33658040
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
    Tayal B, Malahfji M, Buergler JM, Shah DJ, Nagueh SF.
    PLoS One; 2021 Mar 04; 16(2):e0245934. PubMed ID: 33566865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.